encorafenib
Sponsor PFE · listed as PFE
READOUT
Phase 3
Confidence: medium
Source: clinicaltrials
Next catalyst
Event typeREADOUT
Expected date2027-06-30
As disclosedJun 2027
Date precisionmonth
Confidencemedium
Trial & sponsor
Trial (NCT)NCT05615818
PhasePHASE3
StatusRECRUITING
Lead sponsorUNICANCER
Listed asPFE
Condition(s)Biliary Tract Neoplasms
!
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This is one row of the free CSA sample. The full snapshot carries 2,103 forward catalysts across 139 listed sponsors.
Get the full dataset — $499 → More PFE catalysts